The vaccine appears to be safe and effective against triple-negative breast cancer -- a type that can’t be treated with hormone therapy because it isn’t driven by any of the three hormones that typically fuel breast cancer.

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with triple-negative breast cancer.

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer Center just released the results of a clinical trial showing a new vaccine that is preventing cancer from returning.

New research suggests an experimental vaccine could provide new hope for women diagnosed with an aggressive, hard-to-treat form of breast cancer. This vaccine is effective against triple-negative breast cancer,

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St.

A trial of the vaccine showed it to be "well-tolerated" and to stimulate the immune system. The post New vaccine shows promise in treating aggresive form of breast cancer appeared first on Talker.

When Alicia Fivecoat, a mom of two, felt a golf ball-sized mass under her arm late last year, she said she was devastated to learn just weeks later that she had breast cancer. In